UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051351
Receipt number R000058585
Scientific Title Using optical biometry to predict cycloplegic refraction in children
Date of disclosure of the study information 2023/06/15
Last modified on 2023/06/15 14:36:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Using optical biometry to predict cycloplegic refraction in children

Acronym

Prediction of refraction using biometry

Scientific Title

Using optical biometry to predict cycloplegic refraction in children

Scientific Title:Acronym

Prediction of refraction using biometry

Region

Japan


Condition

Condition

Pediatric patients with refractive errors

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To predict cycloplegic refraction in children by using optical biometry.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To develop prediction models for cycloplegic refraction in children from parameters obtained optical biometry.

Key secondary outcomes

Prediction of left-right differences in refraction using optical biometry


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

20 years-old >

Gender

Male and Female

Key inclusion criteria

Clinical information was available for before and after cyclopentolate application.

Key exclusion criteria

Candidates with diseases of the cornea, lens, or retina, with infectious diseases, with eyelid or orbit abnormalities, or with a history of ocular surgery were excluded from the study.

Target sample size

236


Research contact person

Name of lead principal investigator

1st name Nakao
Middle name
Last name Yoshitaka

Organization

Kimura eye and internal medicine hospital

Division name

Department of ophthalmology

Zip code

7370029

Address

3-15 Takaramachi, Kure, Hiroshima

TEL

0823225544

Email

yoshitaka.nakao@kimura-eye.or.jp


Public contact

Name of contact person

1st name Nakao
Middle name
Last name Yoshitaka

Organization

Kimura eye and internal medicine hospital

Division name

Department of ophthalmology

Zip code

7370029

Address

3-15 Takaramachi, Kure, Hiroshima

TEL

0823225544

Homepage URL


Email

yoshitaka.nakao@kimura-eye.or.jp


Sponsor or person

Institute

Kimura eye and internal medicine hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kimura eye and internal medicine hospital

Address

3-15 Takaramachi, Kure, Hiroshima

Tel

0823225544

Email

yoshitaka.nakao@kimura-eye.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 06 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 12 Month 26 Day

Date of IRB

2019 Year 01 Month 17 Day

Anticipated trial start date

2023 Year 06 Month 15 Day

Last follow-up date

2033 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2023 Year 06 Month 15 Day

Last modified on

2023 Year 06 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058585


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name